AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 16944005 — intervention group
Group type: EXPERIMENTAL
Intervention: Rofecoxib (Vioxx)
Number of subjects: 31
Study 16944005 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 11916198 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction therapy (6 MIU interferon-alpha-2a daily for 4 weeks followed by 3 MIU thrice weekly for 22 weeks)
Number of subjects: 71
Study 11916198 — intervention group
Group type: COMPARATOR
Intervention: Standard interferon therapy (3 MIU interferon-alpha-2a thrice weekly for 26 weeks)
Number of subjects: 71
Study 11916198 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction therapy
Number of subjects: 71
Study 11916198 — intervention group
Group type: COMPARATOR
Intervention: Standard interferon therapy
Number of subjects: 71
Study 10091835 — intervention group
Group type: EXPERIMENTAL
Intervention: Meal rich in used cooking fat (fat 64.4 g)
Number of subjects: 10
Study 10091835 — intervention group
Group type: EXPERIMENTAL
Intervention: Meal rich in unused cooking fat (fat 64.4 g)
Number of subjects: 10
Study 10091835 — intervention group
Group type: EXPERIMENTAL
Intervention: Low fat meal (fat 18.4 g)
Number of subjects: 10
Study 7495927 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 24
Study 7495927 — intervention group
Group type: EXPERIMENTAL
Intervention: GH-releasing hormone (GHRH)
Number of subjects: 24
Study 7495927 — intervention group
Group type: COMPARATOR
Intervention: Somatomedin‐C (Sm‐C) plasma concentrations
Number of subjects: 24
Study 7495927 — intervention group
Group type: COMPARATOR
Intervention: Baseline GH concentrations
Number of subjects: 24
Study 2406126 — intervention group
Group type: EXPERIMENTAL
Intervention: Child-centered, family-focused educational program (4 sessions of 1.5 hours each)
Number of subjects: 236
Study 2406126 — intervention group
Group type: COMPARATOR
Intervention: Traditional lecture format (3 sessions of 2 hours each)
Number of subjects: 236
Study 7208542 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron poly (sorbitol‐gluconic acid) complex (IPSG) 250 mg elemental iron per week for 8 weeks
Number of subjects: 11
Study 7208542 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron poly (sorbitol‐gluconic acid) complex (IPSG) 500 mg elemental iron per week for 8 weeks
Number of subjects: 11
Study 7208542 — intervention group
Group type: COMPARATOR
Intervention: Iron dextran
Number of subjects: 11
Study 7208542 — intervention group
Group type: COMPARATOR
Intervention: Iron sorbitol citrate
Number of subjects: 11
Study 6831362 — intervention group
Group type: EXPERIMENTAL
Intervention: Levamisole (45 mg/m2, orally, twice daily for three consecutive days each week)
Number of subjects: 60
Study 6831362 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone (daunorubicin and cytosine arabinoside for induction and consolidation, methotrexate with citrovorum factor reversal, thioguanine and cytosine arabinoside for late intensification)
Number of subjects: 60
Study 30560280 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined cataract surgery with implantation of 2 iStents inject GTS-400
Number of subjects: 65
Study 30560280 — intervention group
Group type: COMPARATOR
Intervention: Standard cataract surgery without stent implantation
Number of subjects: 65
Study 28965725 — intervention group
Group type: EXPERIMENTAL
Intervention: Cut-and-sew Maze III procedure plus mitral valve replacement (MVR)
Number of subjects: 130
Study 28965725 — intervention group
Group type: COMPARATOR
Intervention: Mitral valve replacement alone (non-Maze)
Number of subjects: 130
Study 26196201 — intervention group
Group type: EXPERIMENTAL
Intervention: 10,000 IU of oral vitamin D3/10 kg body weight per week for 6 weeks
Number of subjects: 32
Study 26196201 — intervention group
Group type: EXPERIMENTAL
Intervention: 5000 IU of oral vitamin D3/10 kg body weight per week for 6 weeks
Number of subjects: 32
Study 26196201 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatment arms
Number of subjects: 32
Study 25012515 — intervention group
Group type: EXPERIMENTAL
Intervention: CX157 treatment
Number of subjects: 360
Study 25012515 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 360
Study 25012515 — intervention group
Group type: COMPARATOR
Intervention: mITT population
Number of subjects: 360
Study 22273828 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramosetron 6 μg/kg
Number of subjects: 405
Study 22273828 — intervention group
Group type: COMPARATOR
Intervention: Ramosetron 6 μg/kg and midazolam 0.1 mg/kg
Number of subjects: 405
Study 20072036 — intervention group
Group type: EXPERIMENTAL
Intervention: Etanercept
Number of subjects: 15
Study 20072036 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 17919233 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose PegIFN-alpha-2b (3.0 microg/kg once weekly for 12 weeks, then 2.0 microg/kg once weekly for 12 weeks, then 1.5 microg/kg once weekly for 48 weeks)
Number of subjects: 53
Study 17919233 — intervention group
Group type: COMPARATOR
Intervention: Standard regimen of PegIFN-alpha-2b (1.5 microg/kg once weekly for 48 weeks)
Number of subjects: 53
Study 15619603 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoprofen (100 mg) before induction of anaesthesia (group K1)
Number of subjects: 104
Study 15619603 — intervention group
Group type: COMPARATOR
Intervention: Propacetamol (2 g) before induction of anaesthesia (group P1)
Number of subjects: 104
Study 15619603 — intervention group
Group type: COMPARATOR
Intervention: Saline before surgery and ketoprofen (100 mg) after surgery (group K2)
Number of subjects: 104
Study 15619603 — intervention group
Group type: COMPARATOR
Intervention: Saline before surgery and propacetamol (2 g) after surgery (group P2)
Number of subjects: 104
Study 12233968 — intervention group
Group type: EXPERIMENTAL
Intervention: Intercostal bupivacaine with epinephrine
Number of subjects: 47
Study 12233968 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control)
Number of subjects: 47
Study 10088167 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal spray (large-particle aerosol)
Number of subjects: 3
Study 10088167 — intervention group
Group type: COMPARATOR
Intervention: Nose drops
Number of subjects: 3
Study 7493058 — intervention group
Group type: EXPERIMENTAL
Intervention: Perfluoroctylbromide (PFOB)
Number of subjects: 0
Study 7493058 — intervention group
Group type: EXPERIMENTAL
Intervention: PFOB
Number of subjects: 0
Study 2189843 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant local graft irradiation (600 cGy in four fractions) with chemical immunosuppression
Number of subjects: 138
Study 2189843 — intervention group
Group type: COMPARATOR
Intervention: Control group (chemical immunosuppression only)
Number of subjects: 138
Study 2189843 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant local graft irradiation
Number of subjects: 138
Study 2189843 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 138
Study 465281 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (1280 mg each)
Number of subjects: 16
Study 465281 — intervention group
Group type: EXPERIMENTAL
Intervention: Dimenhydrinate (Dramamine) (100 mg each)
Number of subjects: 16
Study 31005431 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior-Stabilized (AS) TKA
Number of subjects: 45
Study 31005431 — intervention group
Group type: COMPARATOR
Intervention: Posterior-Stabilized (PS) TKA
Number of subjects: 45
Study 31005431 — intervention group
Group type: EXPERIMENTAL
Intervention: AS TKA
Number of subjects: 45
Study 31005431 — intervention group
Group type: COMPARATOR
Intervention: PS TKA
Number of subjects: 45
Study 29557562 — intervention group
Group type: EXPERIMENTAL
Intervention: Bipolar diathermy-assisted coblation tonsillectomy
Number of subjects: 1684
Study 29557562 — intervention group
Group type: COMPARATOR
Intervention: Coblation tonsillectomy (control)
Number of subjects: 1684
Study 25872780 — intervention group
Group type: EXPERIMENTAL
Intervention: Open strategy (surgical cut-down of the cephalic vein, with rescue technique if necessary)
Number of subjects: 1154
Study 25872780 — intervention group
Group type: COMPARATOR
Intervention: Direct puncture of the subclavian vein using the Seldinger technique guided by sonography, fluoroscopy or landmark technique
Number of subjects: 1154
Study 23684482 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 154
Study 22017620 — intervention group
Group type: EXPERIMENTAL
Intervention: naproxen/esomeprazole magnesium
Number of subjects: 1234
Study 19626694 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoroscopic guidance (FG)
Number of subjects: 972
Study 19626694 — intervention group
Group type: COMPARATOR
Intervention: Traditional anatomic landmark guidance (TALG)
Number of subjects: 972
Study 16939527 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention (specific lecture + small working group seminars)
Number of subjects: 367
Study 15049387 — intervention group
Group type: EXPERIMENTAL
Intervention: Irbesartan
Number of subjects: 90
Study 15049387 — intervention group
Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 90
Study 11880912 — intervention group
Group type: EXPERIMENTAL
Intervention: Wrap
Number of subjects: 39
Study 11880912 — intervention group
Group type: COMPARATOR
Intervention: Walking cast
Number of subjects: 39
Study 10438985 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose-free medium
Number of subjects: 741
Study 10438985 — intervention group
Group type: COMPARATOR
Intervention: Glucose medium
Number of subjects: 741
Study 8553350 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequent hard physical activities
Number of subjects: 131
Study 8553350 — intervention group
Group type: COMPARATOR
Intervention: Control for age, BMI, dietary factors, smoking status, serum total cholesterol and serum triglycerides
Number of subjects: 131
Study 2178493 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural clonidine (2 micrograms/kg)
Number of subjects: 20
Study 2178493 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular clonidine (2 micrograms/kg)
Number of subjects: 20
Study 6775303 — intervention group
Group type: EXPERIMENTAL
Intervention: pentaerythritol tetranitrate (PETN) 80 mg 8-hourly
Number of subjects: 31
Study 6775303 — intervention group
Group type: COMPARATOR
Intervention: dipyramidole (DPM) 75 mg
Number of subjects: 31
Study 29917154 — intervention group
Group type: EXPERIMENTAL
Intervention: Vignette‐based analyses of adverse events conducted once per month for six consecutive months
Number of subjects: 401
Study 29917154 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 401
Study 29417699 — intervention group
Group type: EXPERIMENTAL
Intervention: Faradic current for 10 min and task-oriented exercises
Number of subjects: 83
Study 29417699 — intervention group
Group type: EXPERIMENTAL
Intervention: Russian current for 10 min and task-oriented exercises
Number of subjects: 83
Study 29417699 — intervention group
Group type: COMPARATOR
Intervention: Task-oriented exercises
Number of subjects: 83
Study 26553159 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone treatment (24 weeks)
Number of subjects: 44
Study 26553159 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment (24 weeks)
Number of subjects: 44
Study 24439653 — intervention group
Group type: EXPERIMENTAL
Intervention: Mouth rinse with pomegranate and chamomile plant extracts
Number of subjects: 0
Study 24439653 — intervention group
Group type: COMPARATOR
Intervention: Chlorhexidine 0.12%
Number of subjects: 0
Study 22721424 — intervention group
Group type: EXPERIMENTAL
Intervention: Individually tailored 12-week home-based exercise training program (interval training on a treadmill and strength training)
Number of subjects: 30
Study 22721424 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 30
Study 21180216 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylephrine 25 microgram
Number of subjects: 90
Study 21180216 — intervention group
Group type: EXPERIMENTAL
Intervention: Ephedrine 5mg
Number of subjects: 90
Study 21180216 — intervention group
Group type: EXPERIMENTAL
Intervention: Mephentermine 6mg
Number of subjects: 90
Study 21180216 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 90
Study 17981851 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group
Number of subjects: 50
Study 17981851 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 50
Study 17981851 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 50
Study 15246912 — intervention group
Group type: EXPERIMENTAL
Intervention: SLV306 (200 mg)
Number of subjects: 0
Study 15246912 — intervention group
Group type: EXPERIMENTAL
Intervention: SLV306 (400 mg)
Number of subjects: 0
Study 15246912 — intervention group
Group type: EXPERIMENTAL
Intervention: SLV306 (800 mg)
Number of subjects: 0
Study 15246912 — intervention group
Group type: EXPERIMENTAL
Intervention: SLV306 (all doses)
Number of subjects: 0
Study 15246912 — intervention group
Group type: EXPERIMENTAL
Intervention: SLV306
Number of subjects: 0
Study 12014484 — intervention group
Group type: EXPERIMENTAL
Intervention: Viewing distance of 0.4 m
Number of subjects: 0
Study 12014484 — intervention group
Group type: EXPERIMENTAL
Intervention: Viewing distance of 1 m
Number of subjects: 0
Study 12014484 — intervention group
Group type: EXPERIMENTAL
Intervention: Viewing distance of 1.5 m
Number of subjects: 0
Study 12014484 — intervention group
Group type: EXPERIMENTAL
Intervention: Viewing distance of 3 m
Number of subjects: 0
Study 9509213 — intervention group
Group type: EXPERIMENTAL
Intervention: EMLA cream (Group A)
Number of subjects: 42
Study 9509213 — intervention group
Group type: COMPARATOR
Intervention: Placebo cream (Group B)
Number of subjects: 42
Study 8092509 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane for laryngeal mask airway insertion (MACLMI)
Number of subjects: 42
Study 8092509 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane for tracheal intubation (MACTI)
Number of subjects: 42
Study 3289804 — intervention group
Group type: COMPARATOR
Intervention: Immunosuppressants (corticosteroids, cyclophosphamide, azathioprine)
Number of subjects: 26
Study 3289804 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunosuppressants (corticosteroids, cyclophosphamide, azathioprine) + Plasma exchange therapy
Number of subjects: 26
Study 30015546 — intervention group
Group type: EXPERIMENTAL
Intervention: Mid-thoracic manipulation (MTM)
Number of subjects: 23
Study 30015546 — intervention group
Group type: COMPARATOR
Intervention: Sham intervention (Control)
Number of subjects: 23
Study 29287674 — intervention group
Group type: EXPERIMENTAL
Intervention: NIRS monitoring
Number of subjects: 40
Study 29287674 — intervention group
Group type: COMPARATOR
Intervention: Conventional monitoring (control group)
Number of subjects: 40
Study 26891101 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate
Number of subjects: 42
Study 26891101 — intervention group
Group type: COMPARATOR
Intervention: Salt mouth rinse
Number of subjects: 42
Study 26891101 — intervention group
Group type: COMPARATOR
Intervention: Citric acid mouth rinse
Number of subjects: 42
Study 26891101 — intervention group
Group type: COMPARATOR
Intervention: De-ionised water mouth rinse
Number of subjects: 42
Study 25633123 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Ponseti method (one cast a week)
Number of subjects: 41
Study 25633123 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated Ponseti technique (casting twice a week)
Number of subjects: 41
Study 24429129 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung volume reduction coils (LVRCs)
Number of subjects: 47
Study 24429129 — intervention group
Group type: COMPARATOR
Intervention: Best medical care (usual care)
Number of subjects: 47
Study 20874740 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (DXM) 0.25 mg/kg twice daily at postnatal day 1 and 2
Number of subjects: 54
Study 20874740 — intervention group
Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 54
Study 18929194 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple decompression
Number of subjects: 449
Study 18929194 — intervention group
Group type: COMPARATOR
Intervention: Anterior transposition (subcutaneous or submuscular)
Number of subjects: 449
Study 16622804 — intervention group
Group type: COMPARATOR
Intervention: IVF
Number of subjects: 60
Study 16622804 — intervention group
Group type: EXPERIMENTAL
Intervention: ICSI
Number of subjects: 60
Study 15011734 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine transdermal patches (17.5 mg/day)
Number of subjects: 11
Study 15011734 — intervention group
Group type: COMPARATOR
Intervention: Placebo transdermal patches
Number of subjects: 11
Study 10920613 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycobacterium w vaccine
Number of subjects: 156
Study 10920613 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 156
Study 8820806 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate mandibular overdentures on two mandibular canines with magnetic attachments
Number of subjects: 74
Study 8820806 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate mandibular overdentures on two mandibular canines without magnetic attachments
Number of subjects: 74
Study 8820806 — intervention group
Group type: COMPARATOR
Intervention: Complete immediate dentures
Number of subjects: 74
Study 8339079 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical PROCUREN (autologous platelet-derived wound healing factors)
Number of subjects: 0
Study 2947151 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimetazidine 60 mg
Number of subjects: 29
Study 2947151 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 30560818 — intervention group
Group type: EXPERIMENTAL
Intervention: Resin infiltration
Number of subjects: 23
Study 30560818 — intervention group
Group type: COMPARATOR
Intervention: Fluoride varnish
Number of subjects: 23
Study 27881151 — intervention group
Group type: EXPERIMENTAL
Intervention: Gentamicin
Number of subjects: 720
Study 27881151 — intervention group
Group type: COMPARATOR
Intervention: Ceftriaxone
Number of subjects: 720
Study 26557261 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone (FP) 500 µg bid, five doses total
Number of subjects: 13
Study 26557261 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 23497111 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple therapy (methotrexate + sulfasalazine + hydroxychloroquine)
Number of subjects: 159
Study 23497111 — intervention group
Group type: EXPERIMENTAL
Intervention: MTX + INF (methotrexate + infliximab)
Number of subjects: 159
Study 23497111 — intervention group
Group type: COMPARATOR
Intervention: MTX responders (control group)
Number of subjects: 159
Study 23497111 — intervention group
Group type: EXPERIMENTAL
Intervention: MTX responders (triple therapy)
Number of subjects: 159
Study 23497111 — intervention group
Group type: EXPERIMENTAL
Intervention: MTX + INF
Number of subjects: 159
Study 21622589 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training (5 times a week for 6 weeks)
Number of subjects: 72
Study 21622589 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training
Number of subjects: 72
Study 18343702 — intervention group
Group type: EXPERIMENTAL
Intervention: 24-hour therapy with artesunate/sulfamethoxypyrazine/pyrimethamine (As/SMP)
Number of subjects: 221
Study 18343702 — intervention group
Group type: COMPARATOR
Intervention: 3-day therapy with artesunate/sulfamethoxypyrazine/pyrimethamine (As/SMP)
Number of subjects: 221
Study 16417952 — intervention group
Group type: EXPERIMENTAL
Intervention: MCV-4 (meningococcal diphtheria toxoid conjugate vaccine)
Number of subjects: 0
Study 16417952 — intervention group
Group type: COMPARATOR
Intervention: Hib vaccine (control group)
Number of subjects: 0
Study 12847152 — intervention group
Group type: EXPERIMENTAL
Intervention: [11C]DTBZ binding in the striatum
Number of subjects: 13
Study 12847152 — intervention group
Group type: EXPERIMENTAL
Intervention: [123I]IBVM binding in the thalamus
Number of subjects: 13
Study 10875180 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic mood device (EMD)
Number of subjects: 0
Study 9167019 — intervention group
Group type: EXPERIMENTAL
Intervention: Classical, low-pressure, whole-leg boots system
Number of subjects: 10
Study 9167019 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel, high-pressure, plantar compression system
Number of subjects: 10
Study 9167019 — intervention group
Group type: EXPERIMENTAL
Intervention: Both pneumatic compression devices under induced venous leg stasis
Number of subjects: 10
Study 9167019 — intervention group
Group type: EXPERIMENTAL
Intervention: Both pneumatic compression devices
Number of subjects: 10
Study 8193732 — intervention group
Group type: EXPERIMENTAL
Intervention: Felodipine 5-20 mg orally once daily for 8 weeks
Number of subjects: 35
Study 8193732 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril 5-20 mg orally once daily for 8 weeks
Number of subjects: 35
Study 8193732 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 3082683 — intervention group
Group type: EXPERIMENTAL
Intervention: CO2 laser surgery
Number of subjects: 63
Study 3082683 — intervention group
Group type: COMPARATOR
Intervention: Electrosurgery (microdiathermy needle)
Number of subjects: 63
Study 31965734 — intervention group
Group type: EXPERIMENTAL
Intervention: Trauma-focused therapy (TFT)
Number of subjects: 49
Study 31965734 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 49
Study 31965734 — intervention group
Group type: COMPARATOR
Intervention: Assertiveness training
Number of subjects: 49
Study 31350967 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (50,000 IU weekly for 2 months)
Number of subjects: 56
Study 31350967 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study 29781787 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-operative cefazolin for 23 hours
Number of subjects: 227
Study 29781787 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 227
Study 26179985 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatment group received a single shockwave treatment with 1000 impulses at 0.19-0.23 mJ/mm²
Number of subjects: 72
Study 26179985 — intervention group
Group type: COMPARATOR
Intervention: Placebo group treated with a deactivated shockwave applicator but acoustic sham
Number of subjects: 72
Study 25163030 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin B6 supplement (daily)
Number of subjects: 1011
Study 25163030 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (without placebo)
Number of subjects: 1011